Chemours Co Stock
€18.70
Your prediction
Chemours Co Stock
Pros and Cons of Chemours Co in the next few years
Pros
Cons
Performance of Chemours Co vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Chemours Co | 0.480% | -0.187% | 21.468% | 55.251% | 83.694% | -31.161% | -21.462% |
| Newmarket Corp. | -1.800% | 2.830% | 2.830% | 4.808% | -8.403% | 66.159% | 69.255% |
| Quaker Chemical Corp. | -2.800% | -3.704% | -16.129% | -7.965% | -14.050% | - | - |
| Axalta Coating Systems Ltd. | -2.520% | -1.695% | -16.547% | -25.161% | -15.942% | -15.942% | -7.163% |
Comments
News
Why Chemours Plunged Today
Shares of European chemicals company Chemours (NYSE: CC) fell 16.8% on Friday, as of 2:46 p.m. EDT.
The chemicals giant reported lackluster earnings today and also provided guidance that merely met
This Chemicals Stock Is Down 32% but Just Became a Top 5 Holding After One Fund's $13 Million Bet
New York City-based Alta Fundamental Advisers initiated a new position in The Chemours Company (NYSE:CC), acquiring 800,000 shares valued at an estimated $12.67 million, according to a November 13
Luminus Trims Its Hefty Chemours Position
Luminus Management LLC reduced its stake in The Chemours Company (NYSE:CC) during Q3 2025, selling shares worth an estimated $4.30 million, based on the average quarterly price, according to an SEC


